Assiut unviresty
Asyut, 71511, Egypt
NCT Number: NCT04085133
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree
Looking for future studies?
Notify Me18 year–50 year
All sexes
Observational
Asyut, 71511, Egypt
Bronchiectasis was described in the early 19th century by Laennec. Bronchiectasis is a chronic condition characterized by permanent and irreversible dilatation of the bronchial airways and impairment of mucociliary transport mechanism due to repeated infection and inflammation leading to colonization of organism and pooling of the mucus in the bronchial tree.
The prevalence of bronchiectasis is age-related and occurs in every age group and in the pre-antibiotic era . it most often began in childhood. Recent evidence shows that bronchiectasis disproportionately affects women and older individuals and will be contributing to increase in healthcare burden.[3] International data show an increase in the prevalence of bronchiectasis over recent years.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
2-patients were diagnosed to have bronchiectasis after lab and radiological examination as well as clinical score.
3- patients diagnosed as bronchiectasis after history of tuberculosis or anti Tuberculosis treatment with positive or negative tuberculous culture in the time of research.
Exclusion criteria
Sputum sample for T.B will be done using gene expert device and chest xray and high resolution ct to evaluate bronchectasis
Time frame: One year
How many patients of TB will be diagnosed as abronchiectasis
Time frame: one year
by frequency of need for hospital admission per year, need for outpatient clinical visits per month and frequency of need for antimicrobial therapy other than anti-tuberculous treatment per month
Assiut University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02754765
Actinomycetales Infections, Bacterial Infections
Tbilisi, Georgia
View Trial DetailsNCT03896685
Actinomycetales Infections, Bacterial Infections
Pune, India
View Trial DetailsNCT04207112
Actinomycetales Infections, Bacterial Infections
Minsk, Belarus
View Trial DetailsNCT05568368
Actinomycetales Infections, Bacterial Infections
Nice, France
View Trial Details